کد مقاله کد نشریه سال انتشار مقاله انگلیسی نسخه تمام متن
5632408 1406535 2017 7 صفحه PDF دانلود رایگان
عنوان انگلیسی مقاله ISI
Pilot phenotype and natural history study of hereditary neuropathies caused by mutations in the HSPB1 gene
موضوعات مرتبط
علوم زیستی و بیوفناوری علم عصب شناسی علوم اعصاب تکاملی
پیش نمایش صفحه اول مقاله
Pilot phenotype and natural history study of hereditary neuropathies caused by mutations in the HSPB1 gene
چکیده انگلیسی


- Mutations in HSPB1 result in a motor predominant neuropathy.
- The mean age of disease onset was in the 4th decade.
- HSPB1 neuropathy is characterised by early plantar flexion weakness.
- Muscle MRI demonstrates selective denervation of gastrocnemius and soleus.

Mutations in HSPB1 are one of the commonest causes of distal Hereditary Motor Neuropathy (dHMN). Transgenic mouse models of the disease have identified HDAC6 inhibitors as promising treatments for the condition paving the way for human trials. A detailed phenotype and natural history study of HSPB1 neuropathy is therefore required in order to inform the duration and outcome measures of any future trials. Clinical and neurophysiological data and lower limb muscle MRI were collected both prospectively and retrospectively from patients with mutations in HSPB1. The natural history was assessed by recording the weighted Charcot-Marie-Tooth Examination Score (CMTES) at annual intervals in a subset of patients. 20 patients from 14 families were recruited into the study. The average age of onset was in the 4th decade. Patients presented with a length dependent neuropathy but with early ankle plantar flexion weakness. Neurophysiology confirmed a motor neuropathy but also showed sensory nerve involvement in most patients. Cross sectional muscle MRI revealed soleus and medial gastrocnemius fat infiltration as an early signature of mutant HSPB1 disease. In this study neither semi quantitative muscle MRI, the CMTES nor neurophysiology were able to detect disease progression in HSPB1 neuropathy over 1 or 2 years. Further studies are therefore required to identify a suitable biomarker before clinical trials in HSPB1 neuropathy can be undertaken.

ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Neuromuscular Disorders - Volume 27, Issue 1, January 2017, Pages 50-56
نویسندگان
, , , , , , , , , ,